NCT04631679 (WASH-OUT) is a clinical trial in Anemia, sponsored by University Hospital Muenster.

Who is sponsoring NCT04631679?

NCT04631679 is sponsored by University Hospital Muenster.

What condition does NCT04631679 study?

NCT04631679 studies Anemia, Anemia, Iron Deficiency, Iron Deficiency Anemia Treatment.

Is NCT04631679 still recruiting?

NCT04631679 is currently completed. Last updated 8 October 2021.

Last reviewed 2021-10-08 · How we verify

NCT04631679: WASH-OUT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of the Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT)

Completed Last updated 8 October 2021

What this trial tests

trial in Anemia in 23 participants. Completed in 29 April 2021.

Timeline

8 November 2019

Primary endpoint
29 April 2021

29 April 2021

Quick facts

Lead sponsor	University Hospital Muenster
Status	Completed
Study type	OBSERVATIONAL
Enrollment	23
Start date	8 November 2019
Primary completion	29 April 2021
Estimated completion	29 April 2021
Sites	1 location across Germany

Conditions studied

Anemia — all drugs for Anemia →
Anemia, Iron Deficiency — all drugs for Anemia, Iron Deficiency →
Iron Deficiency Anemia Treatment — all drugs for Iron Deficiency Anemia Treatment →

Sponsor

University Hospital Muenster

Who can join

18 and older, any sex, with Anemia or Anemia, Iron Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a pilot study, which involves cardiothoracic patients. Patients, who are scheduled for elective cardiosurgical procedure, will be seen in multidisciplinary anesthesia/Patient Blood Management (PBM) clinic and screened for anemia prior to surgery. Anemic patients will eventually be treated with 500mg of ferric carboxymaltose 1 to 4 days prior to surgery. A high blood loss is expected in these procedures (\>500ml). Blood is collected and re-transfused to the patient via use of cell savers/ autologous blood restoration. The investigators will examine how fast intravenous ferric carboxymaltose is stored within the iron storage cells of the body, and how much remains within the patients blood at the time point of surgery. Next, the investigators will assess the wash out effect of iron via cell salvage. The hypothesis of this trial is that ferric carboxymaltose is washed out of the collected patient's blood by cell caver usage (Wash-Out Effect).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anemia

Currently open trials in the same condition.

NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting

Other University Hospital Muenster trials

Trials by the same sponsor.

NCT07414498 — MICRO-SURG: Subgingival Microbiome in Peri-Implantitis, Regenerative, and Resective Periodontal Surgery · NA · not yet recruiting
NCT06999174 — Multiparametric MRI for Characterization of Hepatocellular Carcinoma · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting
NCT06648733 — Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care · NA · recruiting
NCT06464302 — Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized R · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04631679 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Muenster
Last refreshed: 8 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04631679.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing